313 related articles for article (PubMed ID: 38275816)
1. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
Lumahan LEV; Arif M; Whitener AE; Yi P
Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational modification of the androgen receptor in prostate cancer.
van der Steen T; Tindall DJ; Huang H
Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
[TBL] [Abstract][Full Text] [Related]
3. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the androgen receptor by post-translational modifications.
Coffey K; Robson CN
J Endocrinol; 2012 Nov; 215(2):221-37. PubMed ID: 22872761
[TBL] [Abstract][Full Text] [Related]
5. Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.
Jaiswal B; Agarwal A; Gupta A
Front Endocrinol (Lausanne); 2022; 13():886594. PubMed ID: 36060957
[TBL] [Abstract][Full Text] [Related]
6. Post-translational modification of the androgen receptor.
Gioeli D; Paschal BM
Mol Cell Endocrinol; 2012 Apr; 352(1-2):70-8. PubMed ID: 21820033
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis and progression of prostate cancer.
Schrecengost R; Knudsen KE
Semin Oncol; 2013 Jun; 40(3):244-58. PubMed ID: 23806491
[TBL] [Abstract][Full Text] [Related]
9. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
Deng G; Wang R; Sun Y; Huang CP; Yeh S; You B; Feng C; Li G; Ma S; Chang C
Cell Death Differ; 2021 Jul; 28(7):2145-2159. PubMed ID: 34127806
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.
Wang Z; Wang Z; Guo J; Li Y; Bavarva JH; Qian C; Brahimi-Horn MC; Tan D; Liu W
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3053-8. PubMed ID: 22315407
[TBL] [Abstract][Full Text] [Related]
11. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.
Marques RB; Dits NF; Erkens-Schulze S; van Ijcken WF; van Weerden WM; Jenster G
PLoS One; 2011; 6(8):e23144. PubMed ID: 21829708
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
13. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
Correa RG; Krajewska M; Ware CF; Gerlic M; Reed JC
Oncotarget; 2014 Mar; 5(6):1666-82. PubMed ID: 24681825
[TBL] [Abstract][Full Text] [Related]
14. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of AR-mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression.
Cheng Y; Wang D; Jiang J; Huang W; Li D; Luo J; Gu W; Mo W; Wang C; Li Y; Gu S; Xu Y
Prostate; 2020 May; 80(8):640-652. PubMed ID: 32282098
[TBL] [Abstract][Full Text] [Related]
16. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.
Li N; Truong S; Nouri M; Moore J; Al Nakouzi N; Lubik AA; Buttyan R
Oncogene; 2018 Apr; 37(17):2313-2325. PubMed ID: 29429990
[TBL] [Abstract][Full Text] [Related]
17. Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.
Whitworth H; Bhadel S; Ivey M; Conaway M; Spencer A; Hernan R; Holemon H; Gioeli D
PLoS One; 2012; 7(6):e38950. PubMed ID: 22761715
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
[TBL] [Abstract][Full Text] [Related]
19. Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
Cinar B; Al-Mathkour MM; Khan SA; Moreno CS
J Biol Chem; 2020 Jun; 295(25):8550-8559. PubMed ID: 32376689
[TBL] [Abstract][Full Text] [Related]
20. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
